Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 100 of 102 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/31/24
End: 01/31/25
Due: 01/31/26
Phase: N/A
Priority: Normal
Start: 08/31/23
End: 04/30/25
Due: 04/30/26
Phase: N/A
Priority: Normal
Start: 03/30/15
End: 08/11/15
Due: 08/11/16
Phase: N/A
Priority: Normal
Start: 11/30/14
End: 02/29/16
Due: 02/28/17
Safety, Tolerability, Pharmacokinetics and Efficacy Study of HS-10380 in Patients With Schizophrenia
Phase: N/A
Priority: Normal
Start: 07/30/23
End: 12/30/24
Due: 12/30/25
Phase: N/A
Priority: Normal
Start: 04/01/25
End: 02/28/27
Due: 02/28/28
Phase: N/A
Priority: Normal
Start: 03/05/21
End: 08/31/22
Due: 08/31/23
Phase: N/A
Priority: Normal
Start: 11/30/16
End: 11/30/21
Due: 11/30/22
Phase: N/A
Priority: Normal
Start: 05/31/14
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/23/24
End: 09/28/25
Due: 09/28/26
Phase: N/A
Priority: Normal
Start: 05/15/25
End: 08/30/29
Due: 08/30/30
Phase: N/A
Priority: Normal
Start: 03/31/25
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 06/20/19
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 08/01/22
End: 07/30/23
Due: 07/30/24
Phase: N/A
Priority: Normal
Start: 09/25/23
End: 08/31/28
Due: 08/31/29
Phase: N/A
Priority: Normal
Start: 03/31/24
End: 10/31/24
Due: 10/31/25
Phase: N/A
Priority: Normal
Start: 05/30/25
End: 04/30/30
Due: 04/30/31
Phase: N/A
Priority: Normal
Start: 05/16/25
End: 03/31/26
Due: 03/31/27
Phase: N/A
Priority: Normal
Start: 05/07/25
End: 08/31/26
Due: 08/31/27
Phase: N/A
Priority: Normal
Start: 06/30/14
End: 03/31/16
Due: 03/31/17
Phase: N/A
Priority: Normal
Start: 06/30/14
End: 10/31/15
Due: 10/31/16
Phase: N/A
Priority: Normal
Start: 01/31/24
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 07/17/23
End: 12/24/23
Due: 12/24/24
Phase: N/A
Priority: Normal
Start: 12/31/15
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/14/23
End: 12/30/23
Due: 12/30/24